# Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis

> **NCT00244842** · PHASE3 · COMPLETED · sponsor: **Aurinia Pharmaceuticals Inc.** · enrollment: 451 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** voclosporin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00244842
- **Lead sponsor:** Aurinia Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 451 (ACTUAL)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244842, "Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00244842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*